Symbol="CERE"
AssetType="Common Stock"
Name="Cerevel Therapeutics Holdings Inc"
Description="Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various therapies for neuroscientific diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1805387"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 DARTMOUTH STREET, SUITE 502, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4778701000"
EBITDA="-389763008"
PERatio="None"
PEGRatio="None"
BookValue="2.754"
DividendPerShare="0"
DividendYield="0"
EPS="-2.64"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.319"
ReturnOnEquityTTM="-0.813"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.96"
EVToRevenue="-"
EVToEBITDA="-11.68"
Beta="1.387"
num_52WeekHigh="41.46"
num_52WeekLow="22.63"
num_50DayMovingAverage="31.97"
num_200DayMovingAverage="29.51"
SharesOutstanding="156833000"
DividendDate="None"
ExDividendDate="None"
symbol="CERE"
open="30.36"
high="30.85"
low="29.70"
price="30.47"
volume="357392.00"
latest_trading_day="2023-07-28"
previous_close="30.03"
change="0.44"
change_percent="1.4652%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="553310"
Change_recent_avg="0.02"
Delta_recent_avg="1.23"
Variance_recent_avg="0.62"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="955"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_positive_thumbnail_id_2="599"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
